Apple Watch Hypertension Feature Reportedly Gets FDA Nod, to Launch Soon
Briefly

Apple Watch Hypertension Feature Reportedly Gets FDA Nod, to Launch Soon
"Apple's hypertension detection feature will be available on the new Apple Watch Series 11 and Apple Watch Ultra 3 models next week, following clearance from the US Food and Drug Administration (FDA), according to a recent report. At its September 9 launch event, the Cupertino-based company unveiled these watches alongside the Apple Watch SE 3, the iPhone 17 lineup, which includes a slimmer iPhone Air, and the AirPods Pro 3. While the blood pressure monitor won't detect every case of high blood pressure, it could alert users to potential issues."
"The hypertension feature will also be available on the Apple Watch Series 9, Series 10, and Watch Ultra 2 models. According to Apple, the hypertension feature uses data from the Apple Watch's optical heart sensor to track how a user's blood vessels respond to heartbeats over 30 days. If indicators of chronic hypertension or elevated blood pressure are detected, users will receive a notification and be encouraged to consult a healthcare professional."
The hypertension detection feature will be available next week on Apple Watch Series 11 and Apple Watch Ultra 3 after clearance from the US FDA. The feature will also be supported on Apple Watch Series 9, Series 10, and Watch Ultra 2 and will roll out in 150 countries including the US, Hong Kong, and the EU. The feature uses the Apple Watch optical heart sensor to monitor how blood vessels respond to heartbeats over 30 days and notifies users if signs of chronic hypertension or elevated blood pressure are detected. The system was developed with advanced machine learning and data from studies involving over 100,000 participants, and users receiving alerts are encouraged to consult a healthcare professional. Series 11 and Ultra 3 pricing in India starts at Rs. 46,900 and Rs. 89,900 respectively.
Read at Gadgets 360
Unable to calculate read time
[
|
]